...
首页> 外文期刊>Chinese Journal of Contemporary Neurology and Neurosurgery >Thrombectomy with Solitaire stent for treating acute middle cerebral artery occlusion
【24h】

Thrombectomy with Solitaire stent for treating acute middle cerebral artery occlusion

机译:Solitaire支架血栓切除术治疗急性脑中动脉阻塞

获取原文
           

摘要

Objective To assess the efficacy and safety of thrombectomy with Solitaire stent for treatment of acute middle cerebral artery occlusion (MCAO), and to identify the predictive factors for clinical outcome. Methods A total of 25 patients with acute middle cerebral artery (MCA)-M1 segment occlusion were treated by thrombectomy with Solitaire stent. Time from onset to femoral artery puncture, time from femoral artery puncture to recanalization, times of thrombectomy, thrombolytic therapy or not, balloon dilatation and/or stent implantation, intraarterial thrombolysis or not, tirofiban treatment after therapy or not were recorded. Vascular recanalization immediately after procedure was evaluated by Thrombolysis in Cerebral Infarction (TICI). National Institutes of Health Stroke Scale (NIHSS) was used to evaluate neurological function of patients 24 h after operation, and the clinical outcomes were assessed by modified Rankin Scale (mRS) at 90 d after treatment. The occurrence rate of symptomatic intracranial hemorrhage within 24 h after operation and mortality within 90 d after treatment were recorded. Results Median time from onset to femoral artery puncture was 5.00 (4.00, 6.30) h; median time from femoral artery?puncture to recanalization was 2.00 (2.00, 2.50) h; times of thrombectomy was 2 (2, 2); 7 patients (28%) received intravenous thrombolysis before thrombectomy; 6 patients (24%) underwent balloon dilatation only; 3 patients (12%) underwent stent implantation only; 4 patients (16%) underwent balloon dilatation and stent implantation; 4 patients (16%) received intraarterial thrombolysis after thrombectomy; 11 (44%) received tirofiban therapy after operation. There were 20 patients (80% ) of recanalization with TICI 2b-3 grade. The NIHSS score at 24 h after operation was significantly decreased than before procedure [8 (4, 12) score vs. 14 (11, 17) score; Z = -3.532, P = 0.000]. Symptomatic intracranial hemorrhage occurred in 3 patients (12%). At 90 d after treatment, 15 patients (60%) had favorable prognosis (mRS ≤ 2 score). Two patients (8%) died. Univariate and multivariate forward Logistic regression analysis showed the TICI 2b-3 grade was independent factor for favorable prognosis ( OR = 0.316, 95% CI: 0.102-0.982; P = 0.046). Conclusions Thrombectomy with Solitaire stent is safe and effective for treating acute MCAO. With the increase of TICI grade, the prognosis is better. DOI: 10.3969/j.issn.1672-6731.2017.11.004
机译:目的探讨纸牌支架内血栓切除术治疗急性脑中动脉阻塞(MCAO)的疗效和安全性,并确定临床预后的预测因素。方法对25例急性大脑中动脉(MCA)-M1段闭塞的患者行Solitaire支架血栓切除术治疗。记录从发病到股动脉穿刺的时间,从股动脉穿刺到再通的时间,血栓切除术的时间,是否进行溶栓治疗,是否进行球囊扩张和/或支架植入,是否进行动脉内溶栓,治疗后是否进行替罗非班治疗。手术后立即通过脑梗塞溶栓术(TICI)评估血管再通。美国国立卫生研究院卒中量表(NIHSS)用于评估患者术后24小时的神经功能,并在治疗后90天通过改良的兰金量表(mRS)评估临床结果。记录术后24 h内症状性颅内出血的发生率和治疗后90 d内的死亡率。结果从发病到股动脉穿刺的中位时间为5.00(4.00,6.30)h。从股动脉穿刺到再通的中位时间为2.00(2.00,2.50)h;血栓切除术的次数为2(2,2); 7名患者(28%)在血栓切除术前接受了静脉溶栓治疗; 6例(24%)仅接受球囊扩张术; 3例(12%)仅接受支架植入; 4例(16%)接受了球囊扩张和支架植入术;血栓切除术后4例(16%)接受了动脉内溶栓治疗;术后有11(44%)人接受替罗非班治疗。有20例(80%)TICI 2b-3分级再通。术后24小时的NIHSS评分较术前明显降低[8(4,12)评分与14(11,17)评分; Z = -3.532,P = 0.000]。有症状的颅内出血发生3例(12%)。治疗后90 d,有15例(60%)患者预后良好(mRS≤2分)。两名患者(8%)死亡。单因素和多因素前向Logistic回归分析显示TICI 2b-3等级是预后良好的独立因素(OR = 0.316,95%CI:0.102-0.982; P = 0.046)。结论接龙支架血栓切除术治疗急性MCAO是安全有效的。随着TICI等级的升高,预后较好。 DOI:10.3969 / j.issn.1672-6731.2017.11.004

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号